Genetic and molecular mechanisms of chemical atherogenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 621, Issue 1-2, 2007, Pages 18-30

  Ramos, Kenneth S ^a   Partridge, Charles R ^a   Teneng, Ivo ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Atherosclerosis; Chemical injury; Genetics; LINE 1; Osteopontin

Indexed keywords

INTEGRIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL DIFFERENTIATION; CELL GROWTH; CHEMICAL INJURY; EXTRACELLULAR MATRIX; GENE INTERACTION; GENOMIC INSTABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PRIORITY JOURNAL;

ANIMALS; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 34447285944     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.12.009     Document Type: Article

References (117)

1. Association A.H. Heart and Stroke Statistical Update (2005), American Heart Association, Dallas, TX
2. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 2 (1999) 115-126
3. K.S. Ramos, J.K. Kerzee, N.F. Alejandro, K.P. Lu, Vascular toxicology: a cellular and molecular perspective, in: Cardiovascular Toxicology. Target Organ Toxicology Series, Taylor and Francis, 2001, pp. 479-524.
4. Sun Q., Wang A., Jin X., Natanzon A., Duquaine D., Brook R.D., Aguinaldo J.G., Fayad Z.A., Fuster V., Lippmann M., Chen L.C., and Rajagopalan S. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA 294 23 (2005) 3003-3010
5. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43 10 (2004) 1731-1737
6. Borgerding M., and Klus H. Analysis of complex mixtures-cigarette smoke. Exp. Toxicol. Pathol. 57 (2005) 43-73
7. Ramos K.S., and Moorthy B. Bioactivation of polycyclic aromatic hydrocarbon carcinogens within the vascular wall: implications for human atherogenesis. Drug Metab. Rev. 37 4 (2005) 595-610
8. Brasselet C., Durand E., Addad F., Al Haj Zen A., Smeets M.B., Laurent-Maquin D., Bouthors S., Bellon G., de Kleijn D., Godeau G., Garnotel R., Gogly B., and Lafont A. Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. J. Am. Coll. Cardiol. 39 10 (2002) 1680-1685
9. Ramos K., Weber T.J., and Liau G. Vascular smooth muscle cell proliferation: influence of substratum and growth conditions in vitro. Biochem. J. 289 (1983) 57-63
10. Parrish A.R., and Ramos K.S. Differential processing of osteopontin characterizes the proliferative vascular smooth muscle cell phenotype induced by allylamine. J. Cell Biochem. 65 (1997) 267-275
11. Hu H., Pierce G.N., and Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Invest. 103 5 (1999) 747-753
12. Curfs D.M., Lutgens E., Gijbels M.J., Kockx M.M., Daemen M.J., and van Schooten F.J. Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am. J. Pathol. 164 1 (2004) 101-108
13. Shao B., O'brien K.D., McDonald T.O., Fu X., Oram J.F., Uchida K., and Heinecke J.W. Acrolein modifies apolipoprotein A-1 in the Human artery wall. Ann. N.Y. Acad. Sci. 1043 (2005) 395-403
14. Kurtz A.J., and Lloyd R.S. N2-deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via Schiff base linkage. J. Biol. Chem. 278 8 (2003) 5970-5976
15. Cao Z., Hardej D., Trombetta L.D., Trush M.A., and Li Y. Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity. Atherosclerosis 166 2 (2003) 291-301
16. Kontush A., Chancharme L., Escargueil-Blanc I., Therond P., Salvayre R., Negre-Salvayre A., and Chapman M.J. Mildly oxidized LDL particle subspecies are distinct in their capacity to induce apoptosis in endothelial cells: role of lipid hydroperoxides. FASEB J. 1 (2003) 88-90
17. Taylor A.E. Cardiovascular effects of environmental chemicals. Otolaryngeal Head Neck Surg. 114 (1996) 209-211
18. Yamawaki H., and Iwai N. Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells. Circ. J. 70 1 (2006) 129-140
19. Zevin S., Saunders S., Gourlay S.G., Jacob P., and Benowitz N.L. Cardiovascular effects of carbon monoxide and cigarette smoking. J. Am. Coll. Cardiol. 38 6 (2001) 1633-1638
20. Milei J., Parodi J.C., Fernandez A.G., Barone A., Beigelman R., Ferreira L.M., Arrigoni G., and Matturri L. Carotid atherosclerosis. Immunocytochemical analysis of the vascular and cellular composition in endarterectomies. Cardiologia 41 6 (1996) 535-542
21. Gimbrone M.A. Vascular Endothelium, hemodynamic forces, and atherogenesis. Am. J. Pathol. (1999) 1551-1555
22. Stoll G., and Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 7 (2006) 1923-1932
23. Fan Y.-Y., Chapkin R.S., and Ramos K.S. A macrophage-smooth muscle cell co-culture model: Applications in the study of atherogenesis. In Vitro Cell. Dev. Biol. 31 (1995) 492-493
24. Fan Y.-Y., Ramos K.S., and Chapkin R.S. Dietary gamma-linolenic acid modulates macrophage-vascular smooth muscle cell interactions. Evidence for a macrophage-derived soluble factor that downregulates DNA synthesis in smooth muscle cells. Arterios. Thromb. Vasc. Biol. 15 (1995) 1397-1403
25. Fan Y.-Y., Ramos K.S., and Chapkin R.S. Dietary lipid source alters macrophage/vascular smooth muscle cell interactions in vitro. J. Nutr. 126 (1996) 2083-2088
26. Hamer M., and Steptoe A. Influence of specific nutrients on progression of atherosclerosis, vascular function, haemostasis and inflammation in coronary heart disease patients: a systematic review. Br. J. Nutr. 5 (2006) 849-859
27. Kita T., Kume N., Minami M., Hayashida K., Murayama T., Sano H., Moriwaki H., Kataoka H., Nishi, Horiuchi H., Arai H., and Yokode M. Role of oxidized LDL in atherosclerosis. Ann. N.Y. Acad. Sci. 947 (2001) 199-205
28. Nordin Fredrikson G., Hedblad B., Berglund G., and Nilsson J. Plasma oxidized LDL: a predictor for acute myocardial infarction?. J. Intern. Med. 253 4 (2003) 425-429
29. Bennant M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardio. Res. 41 (1999) 361-368
30. Kockx M.M. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler. Thromb. 18 (1998) 1519-1522
31. Devlin A.M., Clark J.S., Reid J.L., and Dominiczak A.F. DNA synthesis and apoptosis in smooth muscle cells from a model of genetic hypertension. Hypertension 36 (2000) 110-115
32. Navab M., Berliner J.A., Watson A.D., Hama S.Y., Territo M.C., Lusis A.J., Shih D.M., Van Lenten B.J., and Frank J.S. Demer. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterio Thromb Vas Bio 16 (1996) 831-842
33. Uzui H., Harpf A., Liu M., Doherty T.M., Shukla A., Chai N.N., Tripathi P.V., Jovinge S., Wilkin D.J., Asotra K., Shah P.K., and Rajavashisth T.B. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 106 24 (2002) 3024-3030
34. Nickenig G., Baudler S., Muller C., Werner C., Werner N., Welzel H., Strehlow K., and Bohm M. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J. 16 9 (2002) 1077-1086
35. Faries P.L., Rohan D.I., Wyers M.C., Marin M.L., Hollier L.H., Quist W.C., and LoGerfo F.W. Vascular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion, migration, and proliferation than venous cells. J. Surg. Res. 104 1 (2002) 22-28
36. Cox L.R., and Ramos K.S. Biochemical basis of allylamine-induced aortic smooth muscle cell proliferation. Chemically-Induced Cell Proliferation: Implications in Risk Assessment (1991), John Wiley and Sons Inc. pp. 429-438
37. Cox L.R., and Ramos K. Allylamine-induced phenotypic modulation of aortic smooth muscle cells. J. Exp. Pathol. 71 1 (1990) 11-18
38. Shanahan C.M., and Weissberg P.L. Smooth muscle cell phenotypes in atherosclerotic lesions. Curr. Opin. Lipidol. 6 (1999) 507-513
39. Hao H., Gabbiani G., and Bochaton-Piallat M.L. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler. Thromb. Vasc. Biol. 23 9 (2003) 1510-1520
40. Yoshida T., and Owens G.K. Molecular determinants of vascular smooth muscle cell diversity. Circ. Res. 96 3 (2005) 280-291
41. Jones J.E., and Nebert D.W. Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. Biochem. Pharmacol. 58 3 (1999) 525-537
42. Hamilton J.A., Myers D., Jessup W., Cochrane F., Byrne R., Whitty G., and Moss S. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler. Thromb. Vasc. Biol. 1 (1999) 98-105
43. Klaunig J.E., and Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 239-267
44. Olinski R., Gackowski D., Foksinski M., Rozalski R., Roszkowski K., and Jaruga P. Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic. Biol. Med. 33 2 (2002) 192-200
45. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15 1 (2005) 11-18
46. Lim M.Y., Wang H., Kapoun A.M., O'connell M., O'Young G., Brauer H.A., Luedtke G.R., Chakravarty S., Dugar S., Schreiner G.S., Protter A.A., and Higgins L.S. p38 Inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells. J. Mol. Cell. Cardiol. 37 6 (2004) 1111-1114
47. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 6 (1994) 1141-1148
48. 2 for platelet-derived growth factor signal transduction. Science 270 5234 (1995) 296-299
49. Brasselet C., Durand E., Addad F., Al Haj Zen A., Smeets M.B., Laurent-Maquin D., Bouthors S., Bellon G., de Kleijn D., Godeau G., Garnotel R., Gogly B., and Lafont A. Collagen and elastin cross-linking: a mechanism of constrictive remodeling after arterial injury. Am. J. Physiol. Heart Circ. Physiol. 289 5 (2005 Nov) H2228-H2233
50. Schiffer R., Klein B., Klosterhalfen B., and Zwadlo-Klarwasser G. The contact of human macrophages with extracellular matrix proteins selectively induces expression of proinflammatory cytokines. Pathobiology 67 5-6 (1999) 233-235
51. Wardman P., and Candeias L.P. Fenton chemistry: an introduction. Radiat. Res. 145 5 (1996) 523-531
52. Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc. Med. 9 5 (1999) 109-113
53. Yu P.H., and Deng Y.L. Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover. Atherosclerosis 140 2 (1998) 357-363
54. Karadi I., Meszaros Z., Csanyi A., Szombathy T., Hosszufalusi N., Romics L., and Magyar K. Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis. Clin. Chim. Acta 323 1-2 (2002) 139-146
55. Wilson E., Parrish A.R., Bral C.M., Williams E.S., and Ramos K.S. Collagen suppresses the proliferative phenotype of allylamine-injured vascular smooth muscle cells. Atherosclerosis 162 2 (2002) 289-297
56. Ross R.S., and Borg T.K. Integrins and the myocardium. Circ. Res. 88 11 (2001) 1112-1119
57. Clark E.A., and Brugge J.S. Integrins and signal transduction pathways: the road taken. Science 268 5208 (1995) 233-239
58. Sheppard D. In vivo functions of intergrins: lessons from null mutations in mice. Matrix Biol. 19 3 (2000) 203-209
59. Bauer J.S., Varner J., Schreiner C., Kornberg L., Nicholas R., and Juliano R.L. Functional role of the cytoplasmic domain of the integrin alpha 5 subunit. J. Cell. Biol. 122 1 (1993) 209-221
60. Hsia D.A., Lim S.T., Bernard-Trifilo J.A., Mitra S.K., Tanaka S., den Hertog J., Streblow D.N., Ilic D., Ginsberg M.H., and Schlaepfer D.D. Integrin alpha4beta1 promotes focal adhesion kinase-independent cell motility via alpha4 cytoplasmic domain-specific activation of c-Src. Mol. Cell. Biol. 25 21 (2005) 9700-9712
61. Masumoto A., and Hemler M.E. Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4: distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin. J. Cell. Biol. 123 1 (1993) 245-253
62. Masumoto A., and Hemler M.E. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J. Biol. Chem. 268 1 (1993) 228-234
63. Zaidel-Bar R., Ballestrem C., Kam Z., and Geiger B. Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells. J. Cell. Sci. 116 (2003) 4605-4613
64. Schlaepfer D.D., Hanks S.K., Hunter T., and van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372 6508 (1994) 786-791
65. Shen Y., and Schaller M.D. Focal adhesion targeting: the critical determinant of FAK regulation and substrate phosphorylation. Mol. Biol. Cell. 10 8 (1999) 2507-2518
66. Benditt E.P., and Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. U.S.A. 70 6 (1973) 1753-1756
67. Zhang Y., and Ramos K.S. The induction of proliferative vascular smooth muscle cell phenotypes by benzo(a)pyrene does not involve mutational activation of ras genes. Mutat. Res. 373 (1997) 285-292
68. Schwartz S.M., and Murry C.E. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu. Rev. Med. 49 (1998) 437-460
69. Ramos K.S. Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: implications in chemical atherogenesis. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 243-265
70. Albert R.E., Vanderlaan M., Burns F.J., and Nishizumi M. Effect of carcinogens on chicken atherosclerosis. Cancer Res. 37 7 Pt 1 (1977) 2232-2235
71. Bond J.A., Gown A.M., Yang H.L., Benditt E.P., and Juchau M.R. Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J. Toxicol. Environ. Health 2 (1981) 327-335
72. Penn A., and Snyder C. Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis 9 12 (1988) 2185-2189
73. Bond J.A., Yang H.Y., Majesky M.W., Benditt E.P., and Juchau M.R. Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in chicken aortas: monooxygenation, bioactivation to mutagens, and covalent binding to DNA in vitro. Toxicol. Appl. Pharmacol. 52 2 (1980) 323-335
74. Juchau M.R., Bond J.A., and Benditt E.P. Aryl 4-monooxygenase and cytochrome P-450 in the aorta: possible role in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 73 10 (1976) 3723-3725
75. Bond J.A., Omiecinski C.J., and Juchau M.R. Kinetics, activation, and induction of aortic mono-oxygenases-biotransformation of benzo[a]pyrene. Biochem. Pharmacol. 28 2 (1979) 305-311
76. Kerzee J.K., and Ramos K.S. Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells: role of the Ahr bHLH/PAS transcription factor. Circ. Res. 89 7 (2001) 563-565
77. Bond J.A., Kocan R.M., Benditt E.P., and Juchau M.R. Metabolism of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene in cultured human fetal aortic smooth muscle cells. Life Sci. 25 (1979) 425-430
78. Majesky M., Yang H.Y., Benditt E.P., and Juchau M. Carcinogenesis and atherogenesis: differences in mono-oxygenase inducibility and bioactivation of benzo(a)pyrene in aortic and hepatic tissue of atherosclerosis-susceptible versus resistant pigeons. Carcinogenesis 4 (1983) 647-652
79. Sharman J.F., Coombes J.S., Geraghty D.P., and Fraser D.I. Exposure to automotive pollution increases plasma susceptibility to oxidation. Arch. Environ. Health 57 6 (2002) 536-540
80. Neufeld E.J., Mietus-Snyder M., Beiser A.S., Baker A.L., and Newburge J.W. Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles. Circulation 96 5 (1997) 1403-1407
81. Brook R.D., Barry F., Wayne C., Yuling H., George H., Michael L., Russell L., Murray M., Jonathan S., Samet S., Smith Jr. S.C., and Tager I. A Statement for Healthcare Professionals From the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 109 (2004) 2655-2671
82. Ross R., Masuda J., Raines E.W., Gown A.M., Katsuda S., Sasahara M., Malden L.T., Masuko H., and Sato H. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248 4958 (1990) 1009-1012
83. Barrett T.B., and Benditt E.P. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc. Natl. Acad. Sci. U.S.A. 84 4 (1987) 1099-1103
84. O'Donnell K.A., Condon M.E., and Hamburger A.W. Production of platelet-derived growth factorlike protein(s) by a human carcinoma cell line. In Vitro Cell. Dev. Biol. 25 4 (1989) 381-384
85. Bejcek B.E., Li D.Y., and Deuel T.F. Transformation by v-sis occurs by an internal autoactivation mechanism. Science 245 4925 (1989) 1496-1499
86. Simons M., and Rosenberg R.D. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ. Res. 70 4 (1992) 835-843
87. Nakagoshi H., Kanei-Ishii C., Sawazaki T., Mizuguchi G., and Ishii S. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7 6 (1992) 1233-1240
88. Edelman E.R., Simons M., Sirois M.G., and Rosenberg R.D. c-myc in vasculoproliferative disease. Circ. Res. 76 2 (1995) 176-182
89. Miano J.M., Vlasic N., Tota R.R., and Stemerman M.B. Localization of Fos and Jun proteins in rat aortic smooth muscle cells after vascular injury. Am. J. Pathol. 142 3 (1993) 715-724
90. Partridge C.R., Williams E.S., Barhoumi R., Tadesse M.G., Johnson C.D., Lu K.P., Meininger G.A., Wilson E., and Ramos K.S. Novel genomic targets in oxidant-induced vascular injury. J. Mol. Cell. Cardiol. 38 6 (2005) 983-996
91. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59 1 (2000) 13-23
92. Leitinger N., Huber J., Rizza C., Mechtcheriakova D., Bochkov V., Koshelnick Y., Berliner J.A., and Binder B.R. The isoprostane 8-iso-PGF (2alpha) stimulates endothelial cells to bind monocytes: differences from thromboxane-mediated endothelial activation. FASEB J. 15 7 (2001) 1254-1256
93. Waddington E.I., Croft K.D., Sienuarine K., Latham B., and Puddey I.B. Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates. Atherosclerosis 167 1 (2003) 111-120
94. Vassalle C., Botto N., Andreassi M.G., Berti S., and Biagini A. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron. Artery Dis. 14 3 (2003) 213-218
95. Wu L., and Juurlink B.H. The impaired glutathione system and its up-regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats. J. Hypertens. 19 10 (2001) 1819-1825
96. Esposito F., Cuccovillo F., Morra F., Russo T., and Cimino F. DNA binding activity of the glucocorticoid receptor is sensitive to redox changes in intact cells. Biochim. Biophys. Acta 1260 3 (1995) 308-314
97. Denhardt D.T., Giachelli C.M., and Rittling S.R. Role of osteopontin in cellular signaling and toxicant injury. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 723-749
98. Isoda K., Nishikawa K., Kamezawa Y., Yoshida M., Kusuhara M., Moroi M., Tada N., and Ohsuzu F. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ. Res. 91 1 (2002) 77-82
99. Sadhu D.N., Lundberg M.S., Burghardt R.C., and Ramos K.S. c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype. J. Cell. Physiol. 161 3 (1994) 490-500
100. Bral C.M., and Ramos K.S. Identification of benzo[a]pyrene-inducible cis-acting elements within c-Ha-ras transcriptional regulatory sequences. Mol. Pharmacol. 52 6 (1997) 974-982
101. Miller K.P., Chen Y.H., Hastings V.L., Bral C.M., and Ramos K.S. Profiles of antioxidant/electrophile response element (ARE/EpRE) nuclear protein binding and c-Ha-ras transactivation in vascular smooth muscle cells treated with oxidative metabolites of benzo[a]pyrene. Biochem. Pharmacol. 60 9 (2000) 1285-1296
102. Lu K.P., and Ramos K.S. Identification of genes differentially expressed in vascular smooth muscle cells following benzo(a)pyrene challenge: implications for chemical atherogenesis. Biochem. Biophys. Res. Comm. 253 (1998) 828-833
103. Lu K.P., and Ramos K.S. Redox regulation of a novel L1Md-A2 retrotransposon in vascular smooth muscle cells. J. Biol. Chem. 278 30 (2003) 28201-28209
104. Kazazian Jr. H.H., Wong C., Youssoufian H., Scott A.F., Phillips D.G., and Antonarakis S.E. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332 6160 (1988) 164-166
105. Belgnaoui S.M., Gosden R.G., Semmes O.J., and Haoudi A. Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer. Cancer Cell Int. 6 (2006) 13
106. Suter C.M., Martin D.I., and Ward R.L. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int. J. Colorectal. Dis. 19 2 (2004) 95-101
107. Schmidt T., Kubis S., and Heslop-Harrison J.S. Analysis and chromosomal localization of retrotransposons in sugar beet (Beta vulgaris L.): LINEs and Ty1-copia-like elements as major components of the genome. Chromosome Res. 3 6 (1995) 335-345
108. Yang N., Zhang L., and Kazazian Jr. H.H. L1 retrotransposon-mediated stable gene silencing. Nucleic Acids Res. 33 6 (2005) e57
109. Feng Q., Moran J.V., Kazazian Jr. H.H., and Boeke J.D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 87 5 (1996) 905-916
110. Weiner A.M. SINEs and LINEs: the art of biting the hand that feeds you. Curr. Opin. Cell Biol. 14 3 (2002) 343-350
111. Han S.J., and Boeke J.D. LINE-1 retrotransposons: modulators of quantity and quality of mammalian gene expression?. BioEssays 27 8 (2005) 775-784
112. Han J.S., Szak S.T., and Boeke J.D. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 429 6989 (2004) 268-274
113. Trelogan S.A., and Martin S.L. Tightly regulated, developmentally specific expression of the first open reading frame from LINE-1 during mouse embryogenesis. Proc. Natl. Acad. Sci. U.S.A. 92 5 (1995) 1520-1524
114. Badge R.M., and Moran J.V. A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res. 32 13 (2004) 3846-3855
115. Tchenio T., Casella J.F., and Heidmann T. Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res. 28 2 (2000) 411-415
116. Burden A.F., Manley N.C., Clark A.D., Gartler S.M., Laird C.D., and Hansen R.S. Hemimethylation and non-CpG methylation levels in a promoter region of human LINE-1 (L1) repeated elements. J. Biol. Chem. 280 15 (2005) 14413-14419
117. Kuchen S., Seemayer C.A., Rethage J., von Knoch R., Kuenzler P., Beat A.M., Gay R.E., Gay S., and Neidhart M. The L1 retroelement-related p40 protein induces p38delta MAP kinase. Autoimmunity 37 1 (2004) 57-65